NCT06758778 - CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

January 3, 2025

Study Completion Date

March 31, 2025

Conditions

Bioavailability

Interventions

DIETARY_SUPPLEMENT

CreNeuroS CNS Fish Oil Plus Softgel [380 mg of fish oil contains Eicosapentaenoic Acid (EPA) （as EE）342 mg; L-5- Methyltetrahydrofolate 1.875 mg; other Vitamins and Minerals]

Test product

DIETARY_SUPPLEMENT

Vascepa® (Icosapent ethyl) 1000 mg Capsules, Deplin® (L-methylfolate Calcium) 7.5 mg Capsules

Reference product

Trial Locations (1)

500072

GloGen Clinical Research Pvt. Ltd., Hyderabad